Chris Metinko / Crunchbase News:

Genesis Therapeutics, which uses AI to discover and develop small-molecule drugs, raised a $200M Series B co-led by a16z, bringing its total funding to $280M  —  Artificial intelligence and biotech are two of the sectors that have been able to buck the current sluggish pace of venture capital spending.

Chris Metinko / Crunchbase News:

Genesis Therapeutics, which uses AI to discover and develop small-molecule drugs, raised a $200M Series B co-led by a16z, bringing its total funding to $280M  —  Artificial intelligence and biotech are two of the sectors that have been able to buck the current sluggish pace of venture capital spending.

Source: TechMeme
Source Link: http://www.techmeme.com/230821/p26#a230821p26